Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI.

MLA

Bitran, Stella, et al. “Do Early Changes in the HAM-D-17 Anxiety/Somatization Factor Items Affect the Treatment Outcome among Depressed Outpatients? Comparison of Two Controlled Trials of St John’s Wort (Hypericum Perforatum) versus a SSRI.” International Clinical Psychopharmacology, vol. 26, no. 4, July 2011, pp. 206–12. EBSCOhost, https://doi.org/10.1097/YIC.0b013e328343ba08.

APA

Bitran, S., Farabaugh, A. H., Ameral, V. E., LaRocca, R. A., Clain, A. J., Fava, M., & Mischoulon, D. (2011). Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John’s wort (Hypericum perforatum) versus a SSRI. International Clinical Psychopharmacology, 26(4), 206–212. https://doi.org/10.1097/YIC.0b013e328343ba08

Chicago

Bitran, Stella, Amy H Farabaugh, Victoria E Ameral, Rachel A LaRocca, Alisabet J Clain, Maurizio Fava, and David Mischoulon. 2011. “Do Early Changes in the HAM-D-17 Anxiety/Somatization Factor Items Affect the Treatment Outcome among Depressed Outpatients? Comparison of Two Controlled Trials of St John’s Wort (Hypericum Perforatum) versus a SSRI.” International Clinical Psychopharmacology 26 (4): 206–12. doi:10.1097/YIC.0b013e328343ba08.